We are live on ! Find out more
DILIC

Dai-ichi Life Insurance Company Portfolio holdings

AUM $3.49B
1-Year Est. Return 27.28%
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
+27.28%
3 Year Est. Return
+89.46%
5 Year Est. Return
+101.23%
10 Year Est. Return
AUM
$7.99B
AUM Growth
+$735M
Cap. Flow
+$293M
Cap. Flow %
3.67%
Top 10 Hldgs %
44.59%
Holding
574
New
31
Increased
141
Reduced
167
Closed
19

Sector Composition

Rank Sector Weight
1 Technology 16.71%
2 Healthcare 9.23%
3 Financials 7.88%
4 Consumer Staples 6.66%
5 Consumer Discretionary 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSA icon
51
Public Storage
PSA
$60.7B
$27.8M 0.35%
92,392
+29,702
+47% +$8.33M
PYPL icon
52
PayPal
PYPL
$50.3B
$27.8M 0.35%
95,241
-5,772
-6% -$1.52M
TMUS icon
53
T-Mobile US
TMUS
$190B
$27.4M 0.34%
189,233
+42,715
+29% +$5.89M
DG icon
54
Dollar General
DG
$26.5B
$27.1M 0.34%
125,199
+47,543
+61% +$9.99M
TGT icon
55
Target
TGT
$69.7B
$26.1M 0.33%
107,904
+73,668
+215% +$16.1M
CRM icon
56
Salesforce
CRM
$158B
$26.1M 0.33%
106,646
-10,674
-9% -$2.46M
MS icon
57
Morgan Stanley
MS
$343B
$26M 0.33%
283,569
+44,807
+19% +$3.84M
TMO icon
58
Thermo Fisher Scientific
TMO
$223B
$25.9M 0.32%
51,250
+2,781
+6% +$1.31M
VYM icon
59
Vanguard High Dividend Yield ETF
VYM
$84.1B
$25.3M 0.32%
241,732
+66,915
+38% +$7.03M
PAYX icon
60
Paychex
PAYX
$42.6B
$24.2M 0.3%
225,304
+69,128
+44% +$6.95M
REGN icon
61
Regeneron Pharmaceuticals
REGN
$82.4B
$24.1M 0.3%
43,094
+12,817
+42% +$6.49M
QCOM icon
62
Qualcomm
QCOM
$172B
$24M 0.3%
167,702
+23,980
+17% +$3.24M
PGR icon
63
Progressive
PGR
$121B
$24M 0.3%
243,939
+70,044
+40% +$6.93M
VRTX icon
64
Vertex Pharmaceuticals
VRTX
$133B
$23.5M 0.29%
116,347
+30,000
+35% +$6.28M
WM icon
65
Waste Management
WM
$90.5B
$23.3M 0.29%
166,627
+44,585
+37% +$6.16M
GIS icon
66
General Mills
GIS
$20.4B
$23.2M 0.29%
380,231
+210,222
+124% +$13M
BLK icon
67
Blackrock
BLK
$180B
$23.1M 0.29%
26,424
+2,938
+13% +$2.48M
CLX icon
68
Clorox
CLX
$12.8B
$21.6M 0.27%
120,145
+28,744
+31% +$5.25M
ZTS icon
69
Zoetis
ZTS
$30.4B
$21.3M 0.27%
114,101
+21,878
+24% +$3.8M
T icon
70
AT&T
T
$167B
$21.2M 0.26%
973,651
-2,632,160
-73% -$59.9M
CVX icon
71
Chevron
CVX
$386B
$21.1M 0.26%
201,758
-12,460
-6% -$1.32M
GS icon
72
Goldman Sachs
GS
$301B
$20.8M 0.26%
54,731
-207
-0.4% -$74.1K
LOW icon
73
Lowe's Companies
LOW
$122B
$20.7M 0.26%
106,590
-774
-0.7% -$151K
IBM icon
74
IBM
IBM
$221B
$20.4M 0.26%
145,736
+59,356
+69% +$8.12M
UNP icon
75
Union Pacific
UNP
$174B
$20.3M 0.25%
92,455
-6,037
-6% -$1.34M

Similar funds

Dai-ichi Life Insurance Company's Q2 2021 Portfolio in Review

As of Q2 2021, Dai-ichi Life Insurance Company held 574 positions worth $7.99B, up 10% from $7.26B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Dai-ichi Life Insurance Company deployed $293M of net new capital in Q2 2021, opening 31 new positions and adding to 141 existing holdings. Its largest new stake was Comerica: 100,000 shares worth $7.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AT&T, an estimated $59.9M trimmed.

  • Dai-ichi Life Insurance Company's largest Q2 2021 buy was Comerica: 100,000 shares worth $7.13M.
  • Dai-ichi Life Insurance Company added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2021, an estimated $527M increase.
  • Dai-ichi Life Insurance Company's biggest Q2 2021 reduction was AT&T, cutting an estimated $59.9M.
  • Dai-ichi Life Insurance Company fully exited Vanguard S&P 500 ETF in Q2 2021, selling an estimated $214M.
  • Dai-ichi Life Insurance Company's ten largest holdings make up 45% of its $7.99B portfolio in Q2 2021.
  • Dai-ichi Life Insurance Company opened 31 new positions and closed 19 in Q2 2021.
  • Dai-ichi Life Insurance Company's portfolio value rose 10% quarter-over-quarter to $7.99B.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2021, filed 13 Aug 2021.